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Abstract
Introduction Dupuytren’s disease (DD) causes progressive
digital flexion contracture and is more common in men of
European descent.
Methods Orthopaedic and plastic surgeons in 12 European
countries (the Czech Republic, Denmark, Finland, France,
Germany, Hungary, Italy, The Netherlands, Poland, Spain,
Sweden and the UK) with >3 and <30 years experience
reviewed the medical charts of five consecutive patients
they had treated surgically for DD in 2008. Descriptive
statistics are reported.
Results In total, 3,357 patient charts were reviewed. Mean
(standard deviation) patient age was 61.9 (10.2) years; 81%
were men. At the time of the procedure, 11% of patients
were at Tubiana stage Ia (0–20° total flexion); 30%, stage Ib
(21–45°); 34%, stage II (46–90°); 17%, stage III (91–135°);
and 5%, stage IV (>135°). Percutaneous needle fasciotomy
was performed in 10%, fasciotomy in 13%, fasciectomy in
69% and dermofasciectomy (DF) in 6% of patients. After
surgery, fingers improved a mean of 1.9 Tubiana stages, and
54% of patients had no nodules or contracture. The rate of
reported complications during the procedure was 4% overall
(11% in patients undergoing DF). The most common post-
operative complications reported were haematoma (8%),
wound healing complications (6%) and pain (6%). No post-
operative complications were reported in 77% of patients.
Conclusions In this European study of more than 3,000
patients with DD, most patients were diagnosed at Tubiana
stage I or II, the majority received fasciectomy and more than
half had no nodules or contracture remaining after surgery.
Keywords Dupuytren’sdisease.Cordcontracture.
Fasciectomy.Fasciotomy.Percutaneousneedlefasciotomy.
Dermofasciectomy
Introduction
Dupuytren’s disease (DD), a fibroproliferative condition of
the hand causing progressive digital flexion contracture,
most often affects older men of northern European descent
[1] and is more common in patients with diabetes [2].
Estimates of prevalence range from less than 1% to greater
than 50% depending on the population studied [3].
Treatment of Dupuytren’s contracture typically involves
surgery. In order of aggressiveness, surgical procedures
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DOI 10.1007/s12570-012-0092-zperformed include percutaneous needle fasciotomy (PNF;
also known as percutaneous needle aponeurotomy or needle
fasciotomy), fasciotomy (subcutaneous or open), fasciec-
tomy (also known as regional palmar fasciectomy or apo-
neurectomy), dermofasciectomy (DF) and amputation
[4–7]. Fasciectomy has been reported as the most common
surgical procedure performed for Dupuytren’s contracture in
Europe. A recent analysis of hospital records in England
found that more than 90% of inpatient and outpatient
procedures for palmar fascial fibromatosis were classified
as fasciectomy or revision of fasciectomy [8]. Using data
collected from the French National Hospital Database,
Maravic and Landais [9] found that 88% of procedures
for DD were fasciectomies. In a retrospective analysis in
Erlangen, Germany, Loos et al. [10] found that 95% of
procedures for DD were limited fasciectomies and 5% were
total fasciectomies.
In a recent systematic review, fasciectomy and fasci-
otomy were found to have similar efficacy, with mean im-
provement in degree of contracture ranging from 45% to
90% in various studies [4]. Recurrence occurred in approx-
imately 40% of patients receiving fasciectomy and 60% of
patients receiving fasciotomy, at a median time of about
4 years [4]. In another systematic review, measures of effi-
cacy and recurrence were found to be inconsistent among
studies, making it difficult to compare levels of efficacy
between the procedure types. However, there was some
evidence of a higher rate of recurrence after PNF than after
open procedures [7].
While there have been many local studies of surgical
interventions for Dupuytren’s contracture in Europe, to our
knowledge there has been no large-scale study of surgical
procedures for DD and their outcomes across Europe. Ac-
cordingly, the objective of this study was to assess, across
Europe, the surgical treatment patterns for DD and out-
comes in different stages of disease. This article and its
companion article [11] concerning an associated surgeon
survey, report general findings across all 12 countries.
Methods
The study involved surgeons’ review of medical charts of
patients for whom the surgeon had personally performed a
surgical procedure for DD.
Participating surgeons
Surgeons were recruited from 12 European countries: the
Czech Republic, Denmark, Finland, France, Germany, Hun-
gary, Italy, The Netherlands, Poland, Spain, Sweden and the
UK. Details of recruitment and inclusion criteria for partici-
pating surgeons are described in the companion article [11].
Data collection took place between November 2009 and
January 2010. Surgeons responded to a questionnaire via the
Internet or during a face-to-face interview. Each surgeon
reviewed the medical charts of approximately five patients
they had personally treated with a surgical procedure for DD
between September and December 2008, identified in se-
quential order in the surgeon’s records.
Patients
To be included in the study, patients must have been diag-
nosed with DD and undergone a surgical procedure for the
disease between September and December 2008. The surgi-
cal procedure must have been performed by an orthopaedic
or plastic surgeon; hand surgeons were included in each of
these groups. There were no exclusion criteria.
Interviewers and online data collection
Before the initiation of the study, a central briefing meeting
was conducted to review the study protocol and chart review
instructions with all interviewers involved. When necessary,
additional aid was provided to ensure the consistent collec-
tion of data, both in response to interviewers’ queries and
through regular contact with the agencies overseeing the
interview process.
Surgical procedures
The following surgical procedures were identified in the
questionnaire and defined as follows:
& Needle fasciotomy/aponeurotomy (referred to as PNF in
this article): A small gauge hypodermic needle is inserted
through a skin prick into the Dupuytren’s cord. The bevel
of the needle is used as a blade to divide and release the
contracting bands. This is a blind procedure under local
anaesthetic. No tissue is removed during the procedure
& Fasciotomy: A single or multiple palmar/finger incisions
are made above the Dupuytren’s cord and sharp dissec-
tion is performed to facilitate release. In this study,
fasciotomy was defined as including the following:
– Subcutaneous fasciotomy: The fascia is cut blindly
with a small knife (a number 11 blade) via a stab
wound skin incision. No tissue is removed during
the procedure. This procedure is usually done under
local anaesthetic.
– Open fasciotomy: The overlying skin is opened
exposing the cord. Under visual control, the surgeon
is able to cut and release the Dupuytren’s cord, and
the skin is closed without removing any tissue fas-
cia. This procedure is usually done under local
anaesthetic.
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diseased fascia of the palm and/or digits. For the pur-
poses of this research, fasciectomy includes the follow-
ing terms: limited, local, partial, regional, selective,
segmental, sub-total and total. The procedure requires
general anaesthesia or nerve block. Rehabilitation and
wound care are needed
& Dermofasciectomy: Removal of diseased fascia as well
as diseased skin adjacent to the diseased fascia. This
diseased skin is usually replaced with a skin graft
& Amputation of the affected digit/phalanx
Questionnaire items
A questionnaire was used to elicit information from patient
charts and included items on patient characteristics, referral
history, diagnosis history, the procedure performed, outcome
aftertheprocedureandfollow-up.Surgeonswereinstructedto
report the Tubiana stage of Dupuytren’sc o n t r a c t u r e[ 12]i n
each affected finger by adding together the individual flexion
deformities (deficiency extension) of the metacarpophalan-
geal (MCP), proximal interphalangeal (PIP) and distal inter-
phalangeal (DIP) joints. The Tubiana classification scheme is
widelyused[7]torateseverityofDupuytren’scontractureand
wasmodifiedslightlyforthisinvestigation.Tubianastagesare
described throughout this study as:
& Stage 0: no lesion, healthy
& Stage N: palmar or digital nodule without established
flexion deformity
& Stage Ia: total flexion deformity between 0° and 20°
& Stage Ib: total flexion deformity between 21° and 45°
& Stage II: total flexion deformity between 45° and 90°
& Stage III: total flexion deformity between 91° and 135°
& Stage IV: total flexion deformity exceeding 135°.
The questionnaire was translated into the local language
of each country by translation and fieldwork agencies. The
translated questionnaires were checked by A+A Healthcare
Research and local company affiliates. The textofthe survey
is provided as online supplementary material to this article.
Quality assurance
The data collected was quality controlled before analysis by
the A+A statistical group. Filters were put in place to exclude
data values that were not logically possible (i.e. when the
responding surgeon could not be contacted to correct the
item). Answers outside the accepted range were queried with
the physicians, and qualitative explanations were sought be-
fore the inclusion of the data in the dataset to be analysed.
Data were checked for coherence at the level of the interview
through coherence tests programmed in the questionnaire for
both online and face-to-face interviews. Coherence was
checked again before data processing; any data that did not
conform to the coherence filters set were queried with the
physician that had provided it through a recall process.
Statistical analysis
Descriptive statistics were analysed and are reported as
percentages and means with standard deviations (SD).
Results
Demographics of participants
A total of 687 surgeons participated in the study (Table 1).
Of the responding surgeons, 579 (84%) were orthopaedic
surgeons and 108 (16%) were plastic surgeons. Of the 687
participants, 383 (56%) were hand surgeons, including 339
orthopaedic surgeons and 44 plastic surgeons. Specific
details of the number and types of surgeons interviewed from
each country are provided in the companion article [11].
The surgeons reviewed 3,357 patient charts, reflecting up
to five patients per surgeon who had been treated surgically
for Dupuytren’s contracture; most surgeons reviewed five
patient charts. The greatest numbers of patients (approxi-
mately 450 per country) were from France, Germany, Italy,
Spain and the UK. The fewest patients (approximately 90
per country) were from Denmark, Finland and Sweden.
Of the patients included, 2,734 (81%) were men. Where
information about race could be queried, 99% (2,766 of
2,808) patients were Caucasian/white. The mean (SD) age of
all patients was 61.9 (10.2) years; 1,229 (37%) were aged
more than 65 years and 370 (11%) were aged less than
50 years. The following comorbidities and risk factors were
Table 1 Countries surveyed, number of respondents and number of
patient charts reviewed
Country Surgeon respondents Patient cases reviewed
Czech Republic 40 200
Denmark 23 93
Finland 20 91
France 91 456
Germany 90 450
Hungary 50 250
Italy 90 450
The Netherlands 42 176
Poland 40 200
Spain 90 451
Sweden 18 90
UK 93 450
Total 687 3,357
Eur Orthop Traumatol (2012) 3:31–41 33reported among all patients: 1,412 (42%) smoked (more than
five cigarettes per day), 663 (20%) had type 2 diabetes melli-
tus, 260 (8%) had type 1 diabetes mellitus, 578 (17%) con-
sumed more than three alcoholic drinks per day, 320 (10%)
had a personal history of Dupuytren’sc o n t r a c t u r ea n d7 4 4
(22%) had a family history of Dupuytren’sc o n t r a c t u r e .
Diagnosing and referring physicians
Of all patients, 1,654 (49%) were originally diagnosed by a
general practitioner, 723 (22%) were diagnosed by the re-
sponding surgeon and 437 (13%) were diagnosed by anoth-
er orthopaedic surgeon. The setting of the original diagnosis
was a physician’s office for 1,576 (47%), an outpatient
department for 911 (27%) and in a hospital for 557 (17%).
Among all patients, 1,836 (55%) were referred to the
responding surgeon by a general practitioner, and 362
(11%) were referred by another orthopaedic surgeon. For
1,949 patients (58%), the reason for referral was the need for
a procedure. For 267 patients (8%), the reason for the
referral was for diagnosis or confirmation of diagnosis. A
total of 856 patients (26%) were not referred (i.e. they came
directly to the responding surgeon).
Clinical profile at diagnosis
Symptoms and functional limitations
To the extent recorded by the responding surgeon, symptoms
in all patients that originally led to a diagnosis of DD included
finger flexion towards the palm (2,503; 75%), patient’sc o m -
plaint about functionality (1,916; 57%), lump on the palm or
fingers on physical examination (1,719; 51%), a positive ta-
bletoptest (1,204; 36%), patient’s complaint about appearance
(953; 28%) and patient’s complaint about pain (564; 17%).
Lump on palm or fingers was a more common reason for
diagnosis for patients with a lower Tubiana stage of disease,
whereas finger flexion, positive tabletop test and complaint
about functionality were more common reasons for diagno-
sis for patients with a higher Tubiana stage. The proportion
of patients with pain recorded as a reason for diagnosis was
similar (15% to 18%) for patients with all Tubiana stages.
Surgeons reported that 1,896 (56%) of all patients had
functional limitations at the time of diagnosis affecting
leisure activities and that 1,919 (57%) had functional limi-
tations affecting work activities.
Tubiana stage
At the time of diagnosis, 155 (5%) of all patients were
recorded as having nodules only, 429 (13%) were at Tubiana
stage Ia (0–20° total flexion in the most severely affected
finger), 1,017 (30%) were at stage Ib (21–45°), 1,066 (31%)
were at stage II (46–90°), 502 (15%) were at stage III (91–
135°) and 155 (5%) were at stage IV (more than 135°) (see
Fig. 1 showing stage at time of procedure). Older patients and
men were more often diagnosed with higher stages of disease.
Number of hands, fingers and joints affected
Of all patients, 2,951 (88%) were diagnosed with DD in
only one hand. Of 2,826 right-handed patients, 1,767 (63%)
were diagnosed with Dupuytren’s in the right hand only; of
334 left-handed patients, 237 (71%) were diagnosed in the
left hand only. Of 43 patients identified as ambidextrous, 16
(37%) were diagnosed in the right hand only; 18 (42%) were
diagnosed in the left hand only, and nine (21%) were diag-
nosed in both hands.
Of all patients, 1,280 (38%) were diagnosed with
Dupuytren’s in only one finger, 1,381 (41%) in two fingers
and 696 (21%) in three or more fingers (where fingers
included the thumb). Patients diagnosed with a higher Tubi-
ana stage had more fingers involved more often (Fig. 2).
Of all patients, 228 (7%) were affected in zero joints (had
nodules only), 577 (17%) were affected in one joint, 978
(29%) were affected in two joints, 432 (13%) were affected
in three joints and 569 (17%) were affected in four joints.
The remaining 573 (17%) patients were affected in five or
more joints.
Procedure performed
Tubiana stage at time of procedure
A mean (SD) of 29.9 (46.4) months elapsed between initial
diagnosisandprocedure.Patients’ Tubiana stage atthetimeof
procedurewassimilartothestageatthetimeofdiagnosis:106
(3%) of all patients had nodules only, 366 (11%) were at
Tubiana stage Ia, 999 (30%) were at stage Ib, 1136 (34%)
were at stage II, 567 (17%) were at stage III and 164 (5%)
were at stage IV. The distribution of Tubiana stages was
similar for patients treated by orthopaedic, plastic and hand
surgeons.
Procedures performed
The most aggressive surgical procedure performed for
each patient is shown in Fig. 3. Of 3,357 procedures
performed, 329 (10%) were PNFs, 446 (13%) were fas-
ciotomies, 2,311 (69%) were fasciectomies, 200 (6%)
were DFs and 34 (1%) were amputations. More aggres-
sive procedures were more often performed for patients
with higher stage of disease. The distribution of proce-
dure types performed was similar across surgical special-
ties and similar across patients regardless of risk factors
or comorbidities.
34 Eur Orthop Traumatol (2012) 3:31–41Number of hands, fingers and joints operated
Of all patients, 3,249 (97%) were operated on only one
hand. More patients had only one finger (1,381; 41%) or
on two fingers (1,459; 43%) operated than on three or more
fingers (517; 15%). Patients with a higher stage of disease
were more likely to have more fingers operated, and the
number of fingers operated did not differ appreciably by
surgeon specialty.
Fingers operated closely matched the fingers diagnosed:
2,852 (85%) of all patients were operated on the same
fingers as those diagnosed, 373 (11%) on fewer fingers than
at diagnosis, 89 (3%) on different fingers than at diagnosis
and 43 (1%) on more fingers than at diagnosis. Of all
38%
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Eur Orthop Traumatol (2012) 3:31–41 35patients, 1,353 (62%) were operated on a small finger, 1,496
(68%) on a ring finger, 660 (30%) on a middle finger, 223
(10%) on an index finger and 86 (4%) on a thumb.
Overall, a mean (SD) of 2.9 (1.9) joints per patient and
1.7 (0.7) joints per finger were operated. Of 5,984 fingers
operated, the MCP joint was operated in 4,814 (80%), the
PIP joint in 3,958 (66%) and the DIP joint in 1,202 (20%).
History of previous surgery
Of all patients, 216 (6%) had already received surgery on the
same finger that a procedure was reported for in this study; the
previous surgery had taken place a mean of 54.7 (SD, 38.4)
months earlier. The proportion who had already received sur-
gery on the same finger was greater (38 of 200 patients, 19%)
among patients who received DF in this study.
Of 420 fingers that were reoperated, 216 (51%) received
fasciectomy in this study. Fingers receiving the same procedure
previously performed included 19 (68%) of 28 receiving PNF
inthisstudy,13(26%)of50receivingfasciotomy,157(55%)of
284 receiving fasciectomy and 4 (7%) of those 54 receiving DF.
Site of operation and operating time
More aggressive procedures were performed more often on an
inpatient basis (Fig. 4). Mean operation time was 61.2 (SD,
47%
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36 Eur Orthop Traumatol (2012) 3:31–4133.1) min. Operation time was less than 30 min for 260 (8%),
30 to 60 min for 2,049 (61%) and more than 1 h for 1,036
(31%) of the 3,345 procedures for which this information was
available.Meanoperationtimewaslongerformoreaggressive
procedures: The mean(SD) time to perform the procedure was
38.7 (26.3) min for PNF, 53.3 (33.8) min for fasciotomy, 63.5
(30.2) min for fasciectomy and 89.7 (42.8) min for DF.
As shown in Fig. 4, most patients were not admitted as
inpatients for their surgery. For patients who were admitted
to the hospital, the mean (SD) number of nights spent in the
hospital was 2.3 (1.6) for those receiving PNF, 2.0 (1.4) for
fasciotomy, 2.3 (1.5) for fasciectomy and 2.8 (2.1) for DF.
Bandaging and splinting
Immediately after the procedure, a bulky bandage was applied
for 1,627 (48%) of all patients, a light dressing for 1,041 (31%),
a plaster slab for 612 (18%) and a thermoplastic splint for 396
(12%); a single patient might receive more than one dressing or
splint. The postoperative dressing or splint used varied by
procedure type. Overall, 1,360 (41%) of all patients were given
a night splint, which was used for a mean (SD) of 32.2 (38.1)
nights. Splints were used for a longer period of time following
fasciectomy and DF than following PNF and fasciotomy.
Outcome of procedure
Tubiana stage after procedure
Surgeons reported the best (optimal) result recorded during
the year after surgery. A mean of 2.9 (SD, 1.8) months
elapsed after surgery before the optimal result for the patient
was obtained. This was less than 3 months in 1,677 (50%) of
all patients, 3 to 6 months in 1,588 (47%) and more than
6 months in 86 (3%). Mean (SD) time to obtain the optimal
result was greater for more aggressive procedures: 2.2 (1.5)
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Table 2 Complications occurring during procedures
Total
a
(n03,357)
Percutaneous needle
fasciotomy (n0329)
Fasciotomy
(n0446)
Fasciectomy
(n02,311)
Dermofasciectomy
(n0200)
None 3,230 (96%) 323 (98%) 438 (98%) 2,223 (96%) 179 (90%)
Artery injury 32 (1%) 3 (1%) 1 (0.2%) 22 (1%) 5 (3%)
Nerve injury 67 (2%) 1 (0.3%) 2 (0.5%) 51 (2%) 10 (5%)
Tendon injury 8 (0.2%) 1 (0.3%) 0 4 (0.2%) 3 (2%)
Volar plate injury 27 (1%) 2 (1%) 4 (1%) 14 (1%) 7 (4%)
aTotal includes patients for whom procedure type was not known (n037) or who underwent amputation (n034)
Eur Orthop Traumatol (2012) 3:31–41 37months after PNF, 2.8 (1.8) months after fasciotomy, 2.9
(1.7) months after fasciectomy and 3.5 (2.2) months after DF.
Figure 5 illustrates the Tubiana stage of each finger
before and after the surgical procedure. The optimal Tubiana
stage achieved after surgery was lower than the presurgery
stage for 3,196 (96%) of all patients; 96 (3%) remained at
the same stage and 22 (1%) had a more severe stage after
surgery. The optimal result achieved after surgery was ‘no
nodules/no contracture’ for 1,800 (54%) of all patients,
nodules only for 345 (10%), stage Ia for 878 (26%), stage
Ib for 237 (7%), stage II for 42 (1%) and stage III or IV for
29 (1%). At the time of the optimal result, 1,800 (54%) of all
patients had no fingers affected by Dupuytren’s, 816 (25%)
had one affected finger, 582 (17%) had two affected fingers
and 133 (4%) had three or more affected fingers. The mean
(SD) number of stages of improvement after surgery over all
fingers was 1.9 (1.1); this was 1.5 (0.9) after PNF, 1.7 (1.1)
after fasciotomy, 1.9 (1.1) after fasciectomy and 2.0 (1.2)
after DF.
Complications and adverse events
Of all patients, 3,230 (96%) experienced no complications
during the procedure (Table 2). Complications were most
frequently reported in patients receiving DF, 25 (12%) of
whom experienced a complication, including 10 (5%) who
experienced nerve injury.
Of all patients, 2,571 (77%) reported no postoperative com-
plications (Table 3). The most common postoperative compli-
cations reported in all patients were haematoma (283; 8%),
wound healing complications or delayed healing (207; 6%)
andpain(213;6%).Postoperativecomplicationsoccurredmore
frequently in patients undergoing more aggressive procedures.
Among 329 patients receiving PNF, there were no com-
plications leading to readmission. Among 445 patients
receiving fasciotomy, there were two complications lead-
ing to readmission, both of which involved infection.
Among 2,308 patients receiving fasciectomy, there were
26 complications leading to readmission, of which nine
involved haematoma, seven involved infection and four
required amputation. Among 200 patients receiving DF, there
were 11 complications leading to readmission. These compli-
cations involved pain (six patients), abnormal sensitive reac-
tions (two patients), infection (two patients) and haematoma
(two patients), and one patient required amputation.
Follow-up care
During the year after the procedure was performed, patients
had a mean of 3.8 (SD, 2.1) visits with the responding
surgeon. Following the procedure, 1,335 (40%) of all
patients remained in the care of the responding surgeon
only. This proportion varied somewhat for hand surgeons
and nonhand surgeons: 705 (38%) of 1,875 patients man-
aged by hand specialists were cared for by the surgeon only,
compared with 545 (45%) of 1,216 patients managed by
nonhand surgeons. Of the remaining patients, 1,271 (38%)
were cared for by a physiotherapist or occupational thera-
pist, 486 (14%) by a general practitioner and 284 (8%) by
another surgeon.
Table 3 Complications reported after procedures
Total
a
(n03,357)
Percutaneous needle
fasciotomy (n0329)
Fasciotomy
(n0446)
Fasciectomy
(n02,311)
Dermofasciectomy
(n0200)
None 2,571 (77%) 308 (94%) 363 (81%) 1,720 (74%) 125 (63%)
Infection 73 (2%) 2 (<1%) 9 (2%) 54 (2%) 8 (4%)
Haematoma 283 (8%) 9 (3%) 21 (5%) 226 (10%) 20 (10%)
CRPS
b 18 (<1%) 0 0 17 (<1%) 1 (<1%)
Inflammation 129 (4%) 2 (<1%) 24 (5%) 76 (3%) 23 (12%)
Finger required amputation 7 (<1%) 0 0 4 (<1%) 1 (<1%)
Abnormal sensitive reactions 81 (2%) 0 5 (1%) 63 (3%) 11 (6%)
Necrosis 85 (3%) 0 2 (<1%) 67 (3%) 16 (8%)
Pain 213 (6%) 7 (2%) 32 (7%) 142 (6%) 27 (14%)
Carpal tunnel syndrome/
ulnar nerve compression 5 (<1%) 0 2 (<1%) 3 (<1%) 0
Wound healing complications/delayed healing 207 (6%) 2 (<1%) 10 (2%) 155 (7%) 38 (19%)
Other 7 (<1%) 0 1 (<1%) 5 (<1%) 0
Do not know 29 (1%) 3 (1%) 2 (<1%) 22 (1%) 1 (<1%)
aTotal includes patients for whom procedure type was not known (n037) or who underwent amputation (n034)
bComplex regional pain syndrome or reflex sympathetic dystrophy or algodystrophy
38 Eur Orthop Traumatol (2012) 3:31–41Final condition after surgery and recurrence
At the final evaluation after surgery, which took place
3 months to 1 year after the procedure, patients’ Tubiana
stage was very similar to the optimal stage achieved after
surgery. At the final evaluation, disease stage was no nod-
ules/no contracture for 1,718 (52%) of all patients, nodules
only for 330 (10%), stage Ia for 881 (26%), stage Ib for 233
(7%), stage II for 39 (1%) and stage III or IV for 16 (0.5%).
Regarding patients’ hand function, function in work ac-
tivities was improved for 1,776 (53%) of all patients, was
not improved in 85 (3%) and was unknown in 58 (2%). The
remaining patients had no record of work limitations in their
charts. Function in leisure activities was improved for 1,725
(51%) of all patients, was not improved in 81 (2%) and was
unknown in 90 (3%). There was little change in employ-
ment status after surgery.
During the year after surgery, 3,275 (98%) of all patients
had no further surgical procedures for DD. Of all patients,
27 (1%) had a surgical procedure because of recurrence on
the same finger or joint, 23 (1%) had a previously planned
procedure on another joint and 32 (1%) had a procedure on
another joint because of disease progression. A mean of 8.4
(SD, 4.4) months elapsed between the initial and later pro-
cedures. The rate of reoperation on the same finger or joint
was the highest for patients who initially received DF; this
occurred in 13 (7%) of 200 patients.
When asked about future plans, 3,013 (90%) of all
patients said they did not plan treatment in the next
12 months. Surgeons planned to reoperate on a total of
613 fingers out of 5,961 fingers originally operated (10%
of operated fingers) belonging to 334 (10%) of all patients.
Surgeons’ assessment of outcome
Surgeons reported that they assessed the effectiveness of the
surgical procedures performed by measuring postoperative
extension or flexion for 1,881 (56%) of all patients, assess-
ing functional ability after surgery for 1,511 (45%) or by
conducting a tabletop test for 557 (17%). Surgeons de-
scribed the clinical outcome of the procedure as positive
for 3,296 (98%) of all patients.
Discussion
In this survey, the majority of physicians who conducted
surgery for DD were orthopaedic surgeons, of whom more
than half identified themselves as hand surgeons. In some
countries, a number of surgeries were also performed by
plastic surgeons, some of whom were hand surgeons as
well. As would be expected, approximately half of all
patients were referred to the surgeon by their general
practitioner; a quarter of all patients visited the surgeons
on their own.
The surgeons’ review of their patients’ charts indicated
that the majority of patients affected with DD were male,
which is not unexpected given the historical reports of this
disease [3, 13]. Among the comorbidities observed in this
study, diabetes is notable. DD is common in patients with
type 1 and type 2 diabetes but is generally moderate in
presentation and rarely requires surgery [2]. DD is also
common in patients with impaired glucose tolerance [2].
Almost 30% of all patients in this study had type 1 or more
often type 2 diabetes; these patients had DD severe enough
to warrant surgery.
The relatively large proportion of patients reporting pain
in this study was surprising, given that DD is not usually
associated with pain [12]. However, similar to patients de-
scribed by Viljanto [14], it is possible that some patients’
pain reported in this study was related to a comorbid pa-
thology and not to DD itself.
Most patients in this study reported only one hand
affected by DD in contrast with previous literature
reporting more common bilateral involvement [12].
The reason for this difference is unclear; it is possible
that surgeons may not have examined the other hand if
no difficulty was reported by the patient or that the
second hand was examined but mild DD was not noted
in the patient’s chart. Additionally, contracture may have
developed in the second hand at some time after the
initial diagnosis; this would not have been captured in
this chart review. Also in contrast to previous literature,
more procedures involving DIP joints were noted in this
study than expected. Involvement of the DIP joint is
less commonly reported in the literature as compared
with the MCP and PIP joints [12].
Based on this patient chart review, it was noted that the
Tubiana stage of patients was similar at diagnosis and at the
time of the procedure; approximately 60% of patients were
at stage Ia/Ib, even though patients spent a substantial
amount of time on the waiting list for surgery [11]. This is
consistent with what is known about slow progression of
the disease.
Improvement to a lower Tubiana stage was noted in most
patients after surgery. This improvement is consistent with
previous reports of successful surgical correction for
Dupuytren’s contracture in European patients [4, 5, 7]. As
expected, more aggressive procedures were performed for
patients at higher Tubiana stages, with the most common
procedure being fasciectomy. This is in line with previous
reports on treatments for DD [4].
Surgeons reported that most patients experienced no
complications during or after surgery. Complications were
more common among patients receiving DF, most likely
owing to the severity of disease in these patients and the
Eur Orthop Traumatol (2012) 3:31–41 39more complicated surgical procedure. It is possible that
some complications reported in this study were related to
co-occurring hand disorders such as carpal tunnel syndrome
or ulnar nerve compression.
Very few patients in this study were reoperated within
1 year because of a recurrence of contracture in the same
finger/joint. A wide range of recurrence rates is reported in
the literature, and the low rate in this study falls in this range
[4, 7, 15]. The mechanisms and predictors of recurrence in
DD are obscure, but hypotheses exist [16–18]. In evaluating
the low reported rate of recurrence in this study, it must be
emphasized that recurrence was evaluated only up to 1 year
after surgery, whereas recurrence has been reported in the
literature to occur most often between 3.3 and 4.4 years after
surgery [4]. Moreover, reporting recurrence was not specif-
ically requested in this study, assessment and definition of
recurrence is variable [7] and patients may not have returned
to the surgeon unless functional limitations occurred. There-
fore, some cases of recurrence that did not lead to reopera-
tion within the year of follow-up may have been missed.
To our knowledge, this is the first large survey of DD
conducted in Europe. The large sample size allowed for
efficient estimates of patient characteristics and types of
procedures used across much of Europe. This study has
limitations. First, this was a retrospective review of patient
charts using a prespecified questionnaire; therefore, sur-
geons were reporting information captured in the chart at
the time of treatment. Not all patient charts contained the
information on all areas queried, such as hand function
limitations in work and leisure activities. Second, because
of the nature of surveys, inconsistencies could have been
present across countries, and it is difficult to identify or
account for them. Third, the questionnaire used in this study
did not ask detailed questions about the techniques
employed in each surgery (e.g. the use of Z-plasty proce-
dures and local flaps); therefore, differences in outcomes
related to specific surgical techniques would not have been
captured.
An additional limitation of this study is that the chart
review did not capture costs of patient care, which
include direct (e.g. surgery, rehabilitation) and indirect
(e.g. sick leave) costs [19, 20]. Direct costs include time
in surgery, which in this study ranged from almost
40 min on average for PNF to 90 min for DF. Direct
costs also include time for preoperative procedures,
including preparation of anaesthesia and time spent in
postoperative care. Other direct costs include hospitali-
zation; patients admitted for surgery in this study spent
about two to three nights in the hospital. Indirect costs,
such as sick leave from work, can be even more sub-
stantial than direct costs [19, 21].
It will be interesting to observe how the treatment pat-
terns observed in this study change as new options for
managing DD become available. We advise repeating this
study in 5 years to assess changes in surgical practice, the
proportion of nonsurgical procedures being performed and
consequent effects on recurrence.
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